Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04119102 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04119102 · ClinicalTrials.gov record · last posted 2020-04-30

Duobrii in Combination With Biologics

StatusRecruiting
PhasePhase 4
Started2019-10-14
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 30, 2020 (before its estimated August 1, 2020 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2019-10-04; most recent amendment 2024-03-14. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-03-14
Status change Recruiting→Completedv2
Trial Details
NCT Number NCT04119102
Lead Sponsor Psoriasis Treatment Center of Central New Jersey
Collaborators: Ortho Dermatologics
Conditions Psoriasis
Enrollment 25 participants
Start Date 2019-10-14
Primary Completion 2020-08-01 (estimated)
Study Completion 2020-09-01 (estimated)
Updated on ClinicalTrials.gov 2020-04-30